In human prostate cancer cell lines transfected with the fat-1 gene, proliferation was inhibited through a reduction in GSK-3β phosphorylation and a subsequent downregulation of β-catenin and cyclin D1[46]. The gene discussed is CCND1; the disease is prostate carcinoma.